自然衍生的生物活性化合物作为氧化应激和喘炎症的调节剂
Jangho Lee1, Hyo-Kyoung Choi1, Hee Soon Shin1,2
1Division of Food Functionality Research, Korea Food Research Institute (KFRI), Wanju, 55365, Republic of Korea.
Chinese medicine
|July 2, 2025
概括
喘是一种复杂的呼吸道疾病,全球发病率不断增加. 这篇评论探讨了它的机制,重点关注氧化应激和炎症,以找到更好的治疗方法.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种慢性呼吸道疾病,其全球流行率正在上升.
- 它的多因素病因 (遗传,环境,职业) 复杂化了理解和治疗.
- 由于各种临床表现和伴随性疾病,如亚托皮炎和过敏性鼻炎,因此个性化管理至关重要.
研究的目的:
- 阐明喘复杂的病理机制.
- 确定具有抗氧化和抗炎性能的天然化合物,用于喘管理.
- 提出一个整合性的治疗策略,以改善患者的坚持和减少不良影响.
主要方法:
- 关于喘病理生理学的临床前研究的综述.
- 关于氧化应激和喘炎症的科学文献分析.
- 探索自然衍生生物活性化合物的治疗潜力.
主要成果:
- 氧化应激和炎症反应是喘发作和恶化的关键因素.
- 由于它们的抗氧化和抗炎作用,一些天然化合物显示出对控制喘的希望.
- 目前的治疗方法 (如皮质类固醇) 有局限性和潜在的不良影响.
结论:
- 对喘病理生理学的更深入的理解对于开发新疗法至关重要.
- 自然衍生化合物为更有效,更安全的喘管理提供了潜在的途径.
- 结合传统治疗与天然化合物的综合性方法可以提高长期的喘控制和患者的结果.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
476
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
476
Antiasthma Drugs: Leukotriene Modifiers
495
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
495
Asthma: Pathogenesis and Management
613
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
613
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


